Stock Rich List
#8707 on the rich list of 14,644 insiders

Marshall Urist

EVP, Research & Investments at Royalty Pharma. Based in New York, New York.

$10.1M
in disclosed stock, −$142K (−1.38%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
8707th of 14,644
Companies held
1
Largest holding
RPRX, 100.0% of total
Latest SEC filing
Nov 16, 2026

What the $10.1M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Royalty Pharma RPRX
Class A Ordinary Shares
Through Sandy Lamm LLC125,000$67.72$8.5M83.7%Form 4, Nov 16, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Through IRA19,020$67.72$1.3M12.7%Form 4, Nov 16, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Directly5,341$67.72$362K3.6%Form 4, Nov 16, 2026

Share counts are the amounts Marshall Urist reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 16, 2026SoldRPRX23,592$69.47$1.6MView
Nov 16, 2026SoldRPRX1,408$69.99$99KView
Oct 5, 2026SoldRPRX4,126$57.10$236KView
Sep 28, 2026SoldRPRX4,126$57.88$239KView
Jul 1, 2026SoldRPRX9,099$55.88$508KView
Jun 24, 2026SoldRPRX9,098$55.18$502KView
May 20, 2026SoldRPRX13,684$52.75$722KView
May 14, 2026SoldRPRX13,684$53.06$726KView
Jan 30, 2026SoldRPRX20,000$41.09$822KView
Jan 23, 2026SoldRPRX20,000$40.26$805KView
Jan 16, 2026SoldRPRX20,000$39.52$790KView
Jan 9, 2026SoldRPRX20,000$40.78$816KView
Jan 2, 2026SoldRPRX20,000$38.48$770KView
Dec 26, 2025SoldRPRX20,000$39.32$786KView
Dec 19, 2025SoldRPRX20,000$38.38$768KView
Dec 16, 2025SoldRPRX20,000$38.32$766KView
Dec 5, 2025SoldRPRX23,334$39.15$914KView
Dec 5, 2025SoldRPRX18,242$39.15$714KView
Dec 1, 2025SoldRPRX18,242$39.90$728KView
Dec 1, 2025SoldRPRX23,333$39.93$932KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
8704Shawn Vadala
Chief Financial Officer, Mettler-Toledo International. Columbus, OH
$10.1M−$188K (−1.82%)
8705Scipio Maximus Carnecchia
Chief Executive Officer, Mitek Systems. Centennial, CO
$10.1M−$504K (−4.75%)
8706Abhey Lamba
Chief Financial Officer, RingCentral. Belmont, CA
$10.1M−$590K (−5.51%)
8707Marshall Urist
EVP, Research & Investments, Royalty Pharma. New York, NY
$10.1M−$142K (−1.38%)
8708Julio M. Quintana
Director, Newmont. Indianapolis, IN
$10.1M−$139K (−1.36%)
8709Stanley M. Kuriyama
Director, Matson. Honolulu, HI
$10.1M−$145K (−1.42%)
8710David John Newman
Chief Underwriting Officer, Bowhead Specialty Holdings. New York, NY
$10.1M−$12K (−0.12%)

Other Royalty Pharma insiders

All RPRX insiders

Questions

How much stock does Marshall Urist own?

Marshall Urist holds $10,114,727 in listed stock based on SEC filings and current prices, mostly Royalty Pharma (RPRX). That ranks 8707th on the Stock Rich List.

Is this Marshall Urist's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Marshall Urist last buy or sell stock?

The most recent open-market trade on file is a sale of 23,592 RPRX shares on Nov 16, 2026 at $69.47.